Goldman Sachs enters the final stretch before July 14 earnings with a new wrinkle in the story: the Street is finally moving targets toward the price, and options traders have swung to their most bullish positioning of the past year.
The analyst pivot is the standout development this week. Wells Fargo's Mike Mayo lifted his target from $1,000 to $1,195 on June 24 — the first major-firm target that actually clears the current $1,094 price — while Citigroup raised to $1,100 from $930 the day before. Both maintain ratings rather than upgrade, but the magnitude of the moves signals the Street acknowledging it has been structurally behind the tape. The consensus mean at $959.80 still sits roughly 12% below where GS trades, meaning most models remain anchored well below the current level. JP Morgan's Kian Abouhossein, who raised to $900 earlier this month, is now 18% below the price. The bull case rests on sustained M&A strength and asset management growth; bears point to FICC trading's Q1 miss and a shrinking consumer credit book as reasons to stay cautious on the multiple.
Valuation has re-rated meaningfully to support that caution. The price-to-earnings multiple has expanded by roughly 1.4 turns over the past month to 17.6x, and price-to-book has risen 0.25 turns to 2.86x. Neither is extreme in isolation, but the move has been one-directional and rapid, which is the argument the neutral-rated analysts are making implicitly by refusing to upgrade even as they chase targets higher. The earnings surprise factor score at 72 out of 100 is supportive — GS has consistently beaten estimates — but the 12-month forward EPS trajectory scores only 32, suggesting the consensus growth path looks modest even if results keep beating.
Options positioning has shifted in a way that stands apart from the prior two weeks. The put/call ratio has dropped to 0.86, more than two standard deviations below its 20-day average of 0.95 — the most call-heavy positioning seen in the past year, just above the 52-week low of 0.80. That's a meaningful reversal from the neutral-to-cautious posture described in prior notes. Options buyers are leaning into the upside going into July 14 rather than hedging it. The borrow market offers no countervailing pressure: availability is extraordinarily loose at over 7,000% — roughly 167 million shares available versus the 7.6 million currently short — and cost to borrow has more than halved over the past month to just 0.23%. Shorts face no squeeze mechanics whatsoever.
Short interest itself tells a stubbornly unchanged story. Bears have held their ground for a third consecutive week. SI sits at 2.4% of the free float, essentially flat on the day and up only 1% on the week. The absolute level remains modest, but the direction has been clear since June 5: shorts entered during the post-collapse pullback and have not exited despite GS printing a fresh all-time high. The ORTEX short score at 34.6 — mildly below neutral — confirms this is not a heavily shorted situation, but the persistence of a position that has been wrong by 10% is worth tracking. Morgan Stanley gained 3.7% on the week while Lazard fell 4.0% and Invesco dropped 7.1%, suggesting GS continues to lead the investment banking complex rather than track it.
With the July 14 Q2 print now three weeks out, the question shifts from whether the record-high run is justified to whether Q2 can deliver the investment banking revenue that bulls have priced in. GS saw a near-flat one-day move and a 3.7% five-day move after the most recent prior earnings event, suggesting the stock doesn't typically make dramatic single-session decisions around results — the read-through has tended to play out over a week. Whether the short sellers who have held through a 10% miss finally capitulate, or whether Q2 FICC gives them the vindication they've been waiting for, is what July 14 resolves.
See the live data behind this article on ORTEX.
Open GS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
